Literature DB >> 12540575

Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis.

Wu He1, Arturo Casadevall, Sunhee C Lee, David L Goldman.   

Abstract

The mechanisms by which Cryptococcus neoformans persists in an immunocompetent host are not well understood. Using a rat model of persistent infection, we investigated the ability of pulmonary macrophages (PuM) to phagocytize C. neoformans and produce monocyte chemotactic protein 1 (MCP-1) as a function of the length of time of infection and opsonin. The ability of macrophages to affect serum-mediated phagocytosis varied over the course of infection and was dependent on CD11b/c and CD18 expression. Infection resulted in increased MCP-1 levels within the lung, though the actual amounts varied over the course of infection. Immunohistochemical studies localized MCP-1 expression to macrophages and epithelioid cells. Enhanced production of MCP-1 by PuM from infected rats was confirmed by ex vivo studies. Induction of MCP-1 following serum-mediated phagocytosis was observed for PuM from both infected and noninfected rats and depended on the interaction of C. neoformans with CD11b/c and CD18. Specific antibody was more efficient than serum in promoting phagocytosis and consistently elicited more MCP-1. The relative amount of MCP-1 produced in association with phagocytosis was similar for PuM at all lengths of time of infection. Decreased MCP-1 production was observed for PuM obtained from older rats, including long-term (8 to 10 months)-infected and age-matched controls, suggesting that aging may affect the production of MCP-1 by PuM in response to cryptococcal infection. In summary, our results show that macrophages are an important source of MCP-1 during pulmonary cryptococcosis and that MCP-1 production is actively regulated during infection. Furthermore, we find that phagocytosis of C. neoformans can serve as an important stimulus for MCP-1 production by PuM, though the efficiency of this process is dependent on the opsonin type and may be affected by aging.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540575      PMCID: PMC145381          DOI: 10.1128/IAI.71.2.930-936.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  The pulmonary lesions in cryptococcosis with special reference to subpleural nodules.

Authors:  R K HAUGEN; R D BAKER
Journal:  Am J Clin Pathol       Date:  1954-12       Impact factor: 2.493

2.  Chemokine responses and accumulation of inflammatory cells in the lungs of mice infected with highly virulent Cryptococcus neoformans: effects of interleukin-12.

Authors:  K Kawakami; K Shibuya; M H Qureshi; T Zhang; Y Koguchi; M Tohyama; Q Xie; S Naoe; A Saito
Journal:  FEMS Immunol Med Microbiol       Date:  1999-09

3.  Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes.

Authors:  Rachel M Syme; Jason C L Spurrell; Ernest K Amankwah; Francis H Y Green; Christopher H Mody
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

4.  A defective protein kinase C anchoring system underlying age-associated impairment in TNF-alpha production in rat macrophages.

Authors:  E Corsini; F Battaini; L Lucchi; M Marinovich; M Racchi; S Govoni; C L Galli
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

5.  Age-related decrease in accessory cell function of human alveolar macrophages.

Authors:  G Zissel; M Schlaak; J Müller-Quernheim
Journal:  J Investig Med       Date:  1999-01       Impact factor: 2.895

6.  Epidemiological evidence for dormant Cryptococcus neoformans infection.

Authors:  D Garcia-Hermoso; G Janbon; F Dromer
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

7.  Decreased resistance to primary intravenous Cryptococcus neoformans infection in aged mice despite adequate resistance to intravenous rechallenge.

Authors:  K M Aguirre; G W Gibson; L L Johnson
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.

Authors:  A Casadevall; W Cleare; M Feldmesser; A Glatman-Freedman; D L Goldman; T R Kozel; N Lendvai; J Mukherjee; L A Pirofski; J Rivera; A L Rosas; M D Scharff; P Valadon; K Westin; Z Zhong
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

9.  Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis.

Authors:  D K Henderson; J E Bennett; M A Huber
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

10.  Fcgamma receptor I- and III-mediated macrophage inflammatory protein 1alpha induction in primary human and murine microglia.

Authors:  Xianyuan Song; Scott Shapiro; David L Goldman; Arturo Casadevall; Matthew Scharff; Sunhee C Lee
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more
  12 in total

1.  In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Jatin M Vyas; Stuart M Levitz
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  Immune response and immunotherapy to Cryptococcus infections.

Authors:  Qing Zhou; William J Murphy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  The Cnes2 locus on mouse chromosome 17 regulates host defense against cryptococcal infection through pleiotropic effects on host immunity.

Authors:  Mitra Shourian; Adam Flaczyk; Isabelle Angers; Barbara C Mindt; Jörg H Fritz; Salman T Qureshi
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

4.  Towards identification of the mechanisms of action of parasite-derived peptide GK1 on the immunogenicity of an influenza vaccine.

Authors:  René Segura-Velázquez; Gladis Fragoso; Edda Sciutto; Adelaida Sarukhan
Journal:  Clin Vaccine Immunol       Date:  2009-07-15

5.  Cryptococcal cell morphology affects host cell interactions and pathogenicity.

Authors:  Laura H Okagaki; Anna K Strain; Judith N Nielsen; Caroline Charlier; Nicholas J Baltes; Fabrice Chrétien; Joseph Heitman; Françoise Dromer; Kirsten Nielsen
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

6.  Differential activation of peritoneal cells by subcutaneous treatment of rats with cryptococcal antigens.

Authors:  José L Baronetti; Laura S Chiapello; Ana P Garro; Diana T Masih
Journal:  Clin Vaccine Immunol       Date:  2009-06-03

7.  Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model.

Authors:  Rosemary Santangelo; Hans Zoellner; Tania Sorrell; Christabel Wilson; Christine Donald; Julianne Djordjevic; Yi Shounan; Lesley Wright
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

8.  Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans.

Authors:  Chiara Luberto; Beatriz Martinez-Mariño; Daniel Taraskiewicz; Benjamin Bolaños; Pasquale Chitano; Dena L Toffaletti; Gary M Cox; John R Perfect; Yusuf A Hannun; Edward Balish; Maurizio Del Poeta
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

9.  Trojan Horse Transit Contributes to Blood-Brain Barrier Crossing of a Eukaryotic Pathogen.

Authors:  Felipe H Santiago-Tirado; Michael D Onken; John A Cooper; Robyn S Klein; Tamara L Doering
Journal:  mBio       Date:  2017-01-31       Impact factor: 7.867

Review 10.  Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis.

Authors:  Josie F Gibson; Simon A Johnston
Journal:  Fungal Genet Biol       Date:  2014-12-12       Impact factor: 3.495

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.